Publication

Byline

Location

US Patent Issued to Azitra on Sept. 29 for "Expression of the human lekti gene from the chromosome of Staphylococcus epidermidis" (Connecticut Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,281, issued on Sept. 29, was assigned to Azitra Inc (Branford, Conn.). "Expression of the human lekti gene from the chromosome of Staphylo... और पढ़ें


US Patent Issued to Biotest on Sept. 29 for "Process for preparing immunoglobulin compositions" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,282, issued on Sept. 29, was assigned to Biotest GmbH & Co. KGaA (Dreieich, Germany). "Process for preparing immunoglobulin compositions" ... और पढ़ें


US Patent Issued to The Rockefeller University on Sept. 29 for "Compositions and methods related to human neutralizing antibodies to hepatitis B" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,283, issued on Sept. 29, was assigned to The Rockefeller University (New York). "Compositions and methods related to human neutralizing an... और पढ़ें


US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Sept. 29 for "Lassa virus-specific nanobodies and methods of their use" (Maryland, Connecticut, Massachusetts, District Of Columbia Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,284, issued on Sept. 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Serv... और पढ़ें


US Patent Issued to GRIFOLS DIAGNOSTIC SOLUTIONS on Sept. 29 for "Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,285, issued on Sept. 29, was assigned to GRIFOLS DIAGNOSTIC SOLUTIONS INC. (San Diego). "Anti-human immunodeficiency virus-1 antibodies an... और पढ़ें


US Patent Issued to ALYTAS THERAPEUTICS on Sept. 29 for "Means for specifically eliminating perilipin-1 fragment presenting adipocytes" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,286, issued on Sept. 29, was assigned to ALYTAS THERAPEUTICS GMBH (Jena, Germany). "Means for specifically eliminating perilipin-1 fragmen... और पढ़ें


US Patent Issued to Regeneron Pharmaceuticals on Sept. 29 for "Methods of identifying and evaluating cat allergy gene signatures in a subject by determining a stratified score based on gene expression" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,287, issued on Sept. 29, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Methods of identifying and evaluating cat alle... और पढ़ें


US Patent Issued to UCB BIOPHARMA on Sept. 29 for "Tau-binding antibodies" (British, Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,288, issued on Sept. 29, was assigned to UCB BIOPHARMA SRL (Brussels). "Tau-binding antibodies" was invented by Kerry Louise Tyson (Slough... और पढ़ें


US Patent Issued to Janssen Biotech on Sept. 29 for "Manufacturing methods for producing anti-IL12/IL23 antibody compositions" (Dutch, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,289, issued on Sept. 29, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "Manufacturing methods for producing anti-IL12/IL23 antibody... और पढ़ें


US Patent Issued to GlaxoSmithKline Intellectual Property Development on Sept. 29 for "IL-33 binding antibodies" (British Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,290, issued on Sept. 29, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain). "IL-33 binding... और पढ़ें